Abstract |
The platelet aggregation inhibitory activity of selected xanthine-based adenosine A2A and A2B receptor antagonists was investigated, and attempts were made to explain the observed effects. The selective A2B receptor antagonist PSB-603 and the A2A receptor antagonist TB-42 inhibited platelet aggregation induced by collagen or ADP. In addition to adenosine receptor blockade, the compounds were found to act as moderately potent non-selective inhibitors of phosphodiesterases ( PDEs). TB-42 showed the highest inhibitory activity against PDE3A along with moderate activity against PDE2A and PDE5A. The antiplatelet activity of PSB-603 and TB-42 may be due to inhibition of PDEs, which induces an increase in cAMP and/or cGMP concentrations in platelets. The xanthine-based adenosine receptor antagonists were found to be non-cytotoxic for platelets. Some of the compounds showed anti-oxidative properties reducing lipid peroxidation. These results may provide a basis for the future development of multi-target xanthine derivatives for the treatment of inflammation and atherosclerosis and the prevention of heart infarction and stroke.
|
Authors | Monika Kubacka, Szczepan Mogilski, Marek Bednarski, Krzysztof Pociecha, Artur Świerczek, Noemi Nicosia, Jakub Schabikowski, Michał Załuski, Grażyna Chłoń-Rzepa, Jörg Hockemeyer, Christa E Müller, Katarzyna Kieć-Kononowicz, Magdalena Kotańska |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 24
Issue 17
(Aug 29 2023)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 37686188
(Publication Type: Journal Article)
|
Chemical References |
- Xanthine
- diethylstilbestrol monophosphate
- Adenosine
|
Topics |
- Animals
- Rats
- Xanthine
(pharmacology)
- Blood Platelets
- Adenosine
- Atherosclerosis
|